Donald John Olds
Independent DirectorMr. Donald John Olds, also known as Don, M.Sc., MBA, is Director of Response Pharmaceuticals INC. He is Independent Director of Retension Pharmaceuticals, Inc. from November 2023. Mr. Olds serves as Lead Director at Cannara Biotech Inc since May 2021. He serves as an Independent Director at Cannara Biotech Inc. since November 10, 2020. He had been President and Chief Executive Officer of the NEOMED Institute since January 2017 until May 2019. He is well recognized within the Montreal business community as a leader both within the life science sector and beyond. Mr. Olds served as Chief Operating Officer and Corporate Secretary of Telesta Therapeutics Inc. since January 7, 2014 until 2016, where he was responsible for finance and Investor Relations, manufacturing operations, business development, human resources and strategy. In October 2016, he led the successful sale of Telesta. He serves as Director at Agrinam Acquisition Corporation since January 18, 2022. Mr. Olds serves as Treasurer of Oxfam Quebec (www.oxfam.qc.ca). Mr. Olds has significant corporate governance experience as a Board Member and Chair of both for profit and not for profit organizations and significant financing and licensing experience with a focus on life science and technology companies. He served as the Chief Executive Officer and President at Presagia Corp. from October 2011 to December 2013. He served key executive positions in biotechnology, investment banking, biotechnology and information technology where he has led successful licensing, merger and acquisition and debt and equity transactions for public and private companies Centre Quebecois (www.cqdm.org). Mr. Olds served as the Chief Financial Officer and Vice President of Mediatrix Telecom Inc. from 2000 until 2002. He was a Director of Oxfam International. Mr. Olds served as the Chief Financial Officer and Chief Operating Officer at Aegera Therapeutics Inc., from September 2002 to September 2011. He was responsible for clinical operations, business development, finance, administration and mergers and acquisitions. He is Director of Response Therapeutics. At both Telesta and Aegera, Mr. Olds was responsible for raising in equity financing and leading regional and global licensing transactions with life sciences companies. At Aegera, Mr. Olds led financing and licensing efforts that raised in growth capital and Headed the team that negotiated the successful sale of Aegera in May 2011. Prior to Aegera, he served as the Chief Financial Officer of a private telecom company and managed the technology practice of TD Securities in Quebec. He led the Quebec technology practice of TD Securities Inc., from 1997 to 2002 and served as a Corporate Banker for the same institution, where he was instrumental in arranging billions of dollars of private and public debt and equity for companies operating across a diverse array of industries. Since December 2019, Mr. Olds had also been the Chairman of the Board of Directors for Aifred Health Inc. until 2025 and served as its Executive Chairman since 2024 until 2025. Mr. Olds served as Chairman of Oxfam Quebec. He serves as the Chairman of the Board at The NEOMED Institute. He has been Lead Director and Independent Director at Goodfood Market Corp. since June 2017. He was Independent Director of Acasti Pharma Inc. since April 27, 2018 until October 10, 2023. He serves as a Director of CQDM (Quebec Consortium for Drug Discovery). He served as a Director of BELLUS Health Inc. since May 25, 2012 until February 24, 2015. He serves as a Director of Presagia Corp. He serves as Director of Centre Quebecois. He served as a Director of Alexion Montréal Corp. He served as a Director of Enobia Pharma, Inc. Mr. Olds is a graduate of the University of British Columbia and has an M.Sc. (Agriculture) in Renewable Resources, B.Sc., University of British Columbia and MBA in Finance and Strategy from the McGill University.
Positions
- Company NameRetension Pharmaceuticals, Inc.Stock CodeRTSNPositionIndependent DirectorColleagues
- MJMichael Joseph BerendtExecutive Chairman
- EKEric KellerCo-founder, CEO & Director
- PSPaul SweetnamCo-Founder, Chief Scientific Officer & Secretary
- ADAlexander Duke SchwartzChief Financial Officer
- SBSabine BissonChief Operations Officer
- FMFranklin M. BergerIndependent Director
- OAOmar Al DhaybiMember of Scientific Advisory Board
